SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-017860
Filing Date
2022-05-05
Accepted
2022-05-05 16:18:14
Documents
15
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10037250_8k.htm   iXBRL 8-K 26201
2 EXHIBIT 99.1 brhc10037250_ex99-1.htm EX-99.1 216266
6 image0.jpg GRAPHIC 32875
7 image00002.jpg GRAPHIC 3425
  Complete submission text file 0001140361-22-017860.txt   483755

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cemi-20220505.xsd EX-101.SCH 3920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20220505_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20220505_pre.xml EX-101.PRE 16040
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10037250_8k_htm.xml XML 4052
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 22896565
SIC: 2834 Pharmaceutical Preparations